Influence of a commercial antithrombotic filter on the caval blood flow during neutra and valsalva maneuver

dc.contributor.authorNicolás, M.
dc.contributor.authorLucea, B.
dc.contributor.authorLaborda, A.
dc.contributor.authorPeña, Estefanía
dc.contributor.authorMalvè, Mauro
dc.contributor.departmentIngeniería Mecánica, Energética y de Materialeses_ES
dc.contributor.departmentMekanika, Energetika eta Materialen Ingeniaritzaeu
dc.date.accessioned2020-10-15T11:31:35Z
dc.date.available2020-10-15T11:31:35Z
dc.date.issued2017
dc.description.abstractAnticoagulants are the treatment of choice for pulmonary embolism. When these fail or are contraindicated, vena cava filters are effective devices for preventing clots from the legs from migrating to the lung. Many uncertainties exist when a filter is inserted, especially during physiological activity such as normal breathing and the Valsalva maneuver. These activities are often connected with filter migration and vena cava damage due to the various related vein geometrical configurations. In this work, we analyzed the response of the vena cava during normal breathing and Valsalva maneuver, for a healthy vena cava and after insertion of a commercial Günther-Tulip® filter. Validated computational fluid dynamics (CFD) and patient specific data are used for analyzing blood flow inside the vena cava during these maneuvers. While during normal breathing, the vena cava flow can be considered almost stationary with a very low pressure gradient, during Valsalva the extravascular pressure compresses the vena cava resulting in a drastic reduction of the vein section, a global flow decrease through the cava but increasing the velocity magnitude. This change in the section is altered by the presence of the filter which forces the section of the vena cava before the renal veins to keep open. The effect of the presence of the filter is investigated during these maneuvers showing changes in wall shear stress and velocity patterns.en
dc.description.sponsorshipThis study was supported by the CIBER-BBN financed by the Instituto de Salud Carlos III, by the Spanish Ministry of Science and Technology through the Research Projects Nos. DPI-2010-20746-C03-01 and DPI-2013-44391-P and by the Spanish Ministry of Economy and Competitiveness through the Research Project No. DPI-2016-76630-C2-1-R. The experimental study was supported by the Instituto de Salud Carlos III, through the Research Project No. PI08/1424 and was performed by the Minimally Invasive Techniques Research Group (GITMI) of Aragon Government.en
dc.format.extent13 p.
dc.format.mimetypeapplication/pdfen
dc.identifier.doi10.1115/1.4035983
dc.identifier.issn1932-619X
dc.identifier.urihttps://academica-e.unavarra.es/handle/2454/38411
dc.language.isoengen
dc.publisherASMEen
dc.relation.ispartofJournal of Medical Devices, 2017, 11(3): 031002en
dc.relation.projectIDinfo:eu-repo/grantAgreement/MINECO//DPI2013-44391-P/ES/
dc.relation.projectIDinfo:eu-repo/grantAgreement/ES/1PE/DPI2016-76630/
dc.relation.publisherversionhttps://doi.org/10.1115/1.4035983
dc.rights© 2017 by ASMEen
dc.rights.accessRightsinfo:eu-repo/semantics/openAccess
dc.subjectBlood flowen
dc.subjectFiltersen
dc.subjectFlow (Dynamics)en
dc.subjectPressureen
dc.titleInfluence of a commercial antithrombotic filter on the caval blood flow during neutra and valsalva maneuveren
dc.typeinfo:eu-repo/semantics/article
dc.type.versioninfo:eu-repo/semantics/acceptedVersion
dspace.entity.typePublication
relation.isAuthorOfPublicationaa62429b-fef0-4a2c-9d96-43dbf7f63675
relation.isAuthorOfPublication.latestForDiscoveryaa62429b-fef0-4a2c-9d96-43dbf7f63675

Files

Original bundle
Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
29_Nicolas_InfluenceCommercial.pdf
Size:
433.56 KB
Format:
Adobe Portable Document Format
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed to upon submission
Description: